mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.07 |